Centers for Disease Control and Prevention Issues New Guidelines for Preventing Intravascular Catheter-Related Infections

Share Article

The U.S. Centers for Disease Control and Prevention (CDC) issued a new guideline on the “Prevention of Intravascular Catheter-Related Infections.” This provides a much-needed update on evidence-based practices for preventing the more than 250,000 catheter-associated Bloodstream Infections (CLABSIs) in the United States annually. Professional Disposables International, Inc. (PDI), a leader in infection prevention education, support and products for healthcare settings, highlights two of the new guideline’s recommendations related to antisepsis:

The U.S. Centers for Disease Control and Prevention (CDC) issued a new guideline on the “Prevention of Intravascular Catheter-Related Infections.” This provides a much-needed update on evidence-based practices for preventing the more than 250,000 catheter-associated Bloodstream Infections (CLABSIs) in the United States annually. Professional Disposables International, Inc. (PDI), a leader in infection prevention education, support and products for healthcare settings, highlights two of the new guideline’s recommendations related to antisepsis:

  • Skin Antisepsis: "Prepare clean skin with a greater than 0.5% chlorhexidine-based preparation before central venous catheter insertion, arterial line insertion and during dressing changes.”
  • Ports and Hubs: “Minimize contamination risk by scrubbing the access port with an appropriate antiseptic (chlorhexidine, povidone iodine, an iodophor, or 70% isopropyl alcohol) and accessing the port only with sterile devices."

The change from aqueous 2% to >0.5% alcoholic chlorhexidine-based solutions aligns the CDC guidelines with those of the Association for Professionals in Infection Control and Epidemiology (APIC), Society for Healthcare Epidemiology of American (SHEA), Infectious Disease Society of America (IDSA) and Pedivan. As a result, healthcare providers are able to choose from a number of skin antiseptic products on the market, including Chlorascrub™ from PDI, a 3.15% chlorhexidine/70% isopropyl alcohol formulation.

“PDI is committed to assisting our customers implement the new CDC guidelines with the objective of Targeting Zero Healthcare Associated Infections. We work closely with healthcare professionals to address the challenges of catheter-related infections through clinical support, educational programs and clinical research demonstrating improved patient outcomes and decreased healthcare costs,” said PDI’s Director of Clinical Affairs Dr. Hudson Garrett, Jr.

PDI offers the only complete range of infection prevention products for Environmental Hygiene (Sani-Cloth®), Skin Antisepsis (Chlorascrub™), Hand Hygiene (Sani-Hands®) and Patient Care (Hygea®), along with education and support to help reduce infection rates, control associated costs and, ultimately save lives. PDI serves hospitals, long-term care facilities, laboratories, dental and physician offices throughout the United States and worldwide. http://www.pdipdi.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Debbie Gotthart

201-843-5600
Email >
Visit website